Structures by: Vijayakumar V.
Total: 104
(La0.8 Th0.2)
La0.8Th0.2
Physics Letters A (1985) 108, 83-84
a=3.71Å b=3.71Å c=18.03Å
α=90° β=90° γ=120°
Hantzsch 1,4-dihydropyridine ester
C19H22N2O6
Acta Crystallographica Section B (2009) 65, 3 375-381
a=14.3479(10)Å b=15.2867(11)Å c=8.6765(6)Å
α=90.00° β=90.00° γ=90.00°
Hantzsch 1,4-dihydropyridine ester
C20H25NO6
Acta Crystallographica Section B (2009) 65, 3 375-381
a=7.5530(9)Å b=13.5745(16)Å c=19.154(2)Å
α=90.00° β=90.00° γ=90.00°
Hantzsch 1,4-dihydropyridine ester analog
C17H18N2O4
Acta Crystallographica Section B (2009) 65, 3 375-381
a=8.8420(7)Å b=16.0785(14)Å c=11.2188(10)Å
α=90.00° β=104.606(2)° γ=90.00°
Hantzsch 1,4-dihydropyridine ester
C20H25NO5
Acta Crystallographica Section B (2009) 65, 3 375-381
a=9.7834(7)Å b=7.4749(5)Å c=26.6788(18)Å
α=90.00° β=98.1710(10)° γ=90.00°
12-(3,4,5-Trimethoxyphenyl)-2,3,4,12-tetrahydro-1<i>H</i>-5-oxatetraphen-1-one
C26H24O5
Acta Crystallographica Section E (2016) 72, 6 809-814
a=9.2164(5)Å b=20.3760(9)Å c=21.8731(9)Å
α=90° β=90° γ=90°
4,8,9,10-Tetra(4-methoxyphenyl)-1,3-diazaadamantan-6-one-benzene solvate
C36H36N2O5,C6H6
Acta Crystallographica Section E (2001) 57, 4 o305-o306
a=16.6240(5)Å b=26.0007(16)Å c=8.2207(7)Å
α=90.00° β=90.00° γ=90.00°
4,8,9,10-Tetraphenyl-1,3-diazaadamantan-6-one
C32H28N2O
Acta Crystallographica Section E (2002) 58, 6 o675-o677
a=11.7347(14)Å b=11.6976(13)Å c=17.6391(14)Å
α=90.00° β=94.320(10)° γ=90.00°
4,8,9,10-Tetraphenyl-1,3-diazaadamantan-6-one acetone solvate
2C32H28N2O,C3H6O
Acta Crystallographica Section E (2002) 58, 11 o1210-o1212
a=12.6087(14)Å b=13.7214(12)Å c=17.056(2)Å
α=92.760(10)° β=103.570(10)° γ=111.600(10)°
3-carbethoxy-2,6-diphenyl-4-piperidone
C20H21NO3
Acta Crystallographica Section E (2003) 59, 11 o1672-o1674
a=20.261(4)Å b=7.5561(15)Å c=23.034(5)Å
α=90.00° β=100.11(3)° γ=90.00°
4,8,9,10-Tetrakis(4-chlorophenyl)-1,3-diazaadamantan-6-one
C32H24Cl4N2O
Acta Crystallographica Section E (2001) 57, 9 o860-o862
a=6.818(3)Å b=13.288(4)Å c=30.670(14)Å
α=90.00° β=94.47(3)° γ=90.00°
Aniline derivative
C14H19NO3
Acta Crystallographica Section E (2006) 62, 12 o5367-o5368
a=8.045(2)Å b=9.390(2)Å c=10.419(3)Å
α=72.770(10)° β=77.680(10)° γ=69.490(10)°
3-Acetyl-6-chloro-2-methyl-4-phenylquinolinium hydrogen sulfate
C18H15ClNO,HO4S
Acta Crystallographica Section E (2009) 65, 12 o3144-o3145
a=7.39120(10)Å b=8.85470(10)Å c=13.3413(2)Å
α=92.4850(10)° β=91.8890(10)° γ=99.5390(10)°
7-Chloro-3,3-dimethyl-9-phenyl-1,2,3,4-tetrahydroacridin-1-one
C21H18ClNO
Acta Crystallographica Section E (2009) 65, 12 o3237-o3238
a=9.83750(10)Å b=10.05250(10)Å c=10.10760(10)Å
α=79.1620(10)° β=63.3890(10)° γ=70.9280(10)°
2,4,6,8-Tetrakis(4-fluorophenyl)-3,7-diazabicyclo[3.3.1]nonan-9-one
C31H24F4N2O
Acta Crystallographica Section E (2008) 64, 12 o2496
a=37.1521(9)Å b=7.1458(5)Å c=26.2165(7)Å
α=90.00° β=133.249(4)° γ=90.00°
Diethyl 4-(4-ethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C21H27NO5
Acta Crystallographica Section E (2009) 65, 9 o2247-o2248
a=7.55570(10)Å b=9.56970(10)Å c=14.0553(2)Å
α=85.8440(10)° β=87.6790(10)° γ=81.4580(10)°
Ethyl 2-acetyl-3-(4-chloroanilino)butanoate
C14H18ClNO3
Acta Crystallographica Section E (2009) 65, 9 o2125
a=6.9161(2)Å b=10.1319(3)Å c=11.4063(3)Å
α=87.511(10)° β=80.873(10)° γ=73.367(2)°
Dimethyl 4-(4-ethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C19H23NO5
Acta Crystallographica Section E (2009) 65, 9 o2255-o2256
a=7.41080(10)Å b=9.7459(2)Å c=12.3359(2)Å
α=87.4120(10)° β=86.2440(10)° γ=76.4020(10)°
3,3,6,6-Tetramethyl-9-phenyl-3,4,5,6-tetrahydro-9<i>H</i>-xanthene- 1,8(2<i>H</i>,7<i>H</i>)-dione
C23H26O3
Acta Crystallographica Section E (2009) 65, 4 o916
a=6.0562(5)Å b=19.7680(18)Å c=16.4325(13)Å
α=90.00° β=97.924(3)° γ=90.00°
4-Azido-2-chloro-6-methylquinoline
C10H7ClN4
Acta Crystallographica Section E (2009) 65, 4 o671
a=6.9517(4)Å b=7.6078(6)Å c=10.0191(9)Å
α=75.694(7)° β=82.147(8)° γ=76.532(7)°
1,1'-[4-(2-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl]diethanone
C18H21NO3
Acta Crystallographica Section E (2009) 65, 11 o2877
a=26.5512(6)Å b=7.50770(10)Å c=17.0818(3)Å
α=90.00° β=114.9040(10)° γ=90.00°
Methyl 4-(3-ethoxy-4-hydroxyphenyl)-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylate monohydrate
C15H18N2O5,H2O
Acta Crystallographica Section E (2009) 65, 8 o1921-o1922
a=11.4927(6)Å b=15.3756(8)Å c=8.9240(5)Å
α=90.00° β=95.932(2)° γ=90.00°
1-[5-Acetyl-4-(4-bromophenyl)-2,6-dimethyl-1,4-dihydropyridin-3-yl]ethanone monohydrate
C17H18BrNO2,H2O
Acta Crystallographica Section E (2010) 66, 3 o658-o659
a=13.5236(3)Å b=10.3866(2)Å c=15.0939(3)Å
α=90° β=102.1120(10)° γ=90°
(2<i>E</i>,4<i>E</i>)-1-(6-Chloro-2-methyl-4-phenyl-3-quinolyl)- 5-phenylpenta-2,4-dien-1-one
C27H20ClNO
Acta Crystallographica Section E (2010) 66, 6 o1321
a=6.2464(3)Å b=22.5672(11)Å c=15.2748(7)Å
α=90.00° β=94.6200(10)° γ=90.00°
1-[2,4,6-Trimethyl-3,5-bis(4-oxopiperidin-1-ylmethyl)benzyl]piperidin-4-one
C27H39N3O3
Acta Crystallographica Section E (2010) 66, 6 o1306-o1307
a=7.9315(16)Å b=12.449(3)Å c=14.618(3)Å
α=67.641(3)° β=87.749(4)° γ=73.630(3)°
2,4,6,8-Tetrakis(4-ethylphenyl)-3,7-diazabicyclo[3.3.1]nonan-9-one
C39H44N2O
Acta Crystallographica Section E (2010) 66, 6 o1316
a=13.381(2)Å b=11.8217(17)Å c=19.989(3)Å
α=90° β=99.675(4)° γ=90°
(2<i>E</i>)-1-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one
C25H18ClNO
Acta Crystallographica Section E (2010) 66, 7 o1780
a=9.9250(9)Å b=11.1001(9)Å c=17.4651(15)Å
α=90° β=97.2500(10)° γ=90°
4-Methyl-5-phenyl-1<i>H</i>-pyrazol-3-ol
C10H10N2O
Acta Crystallographica Section E (2010) 66, 7 o1697-o1698
a=26.4082(19)Å b=11.0972(8)Å c=14.1245(10)Å
α=90.00° β=118.9960(10)° γ=90.00°
4-{2-[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3-yl]thiazol- 4-yl}benzonitrile
C25H14ClFN4S
Acta Crystallographica Section E (2010) 66, 9 o2286-o2287
a=10.1412(9)Å b=15.0496(14)Å c=15.8890(14)Å
α=105.518(2)° β=107.869(2)° γ=99.253(2)°
Diethyl 4-(2,4-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C19H21Cl2NO4
Acta Crystallographica Section E (2010) 66, 2 o363
a=15.928(7)Å b=12.266(6)Å c=10.042(5)Å
α=90.00° β=103.962(7)° γ=90.00°
(<i>E</i>)-1-(6-Chloro-2-methyl-4-phenyl-3-quinolyl)-3-(4-ethoxyphenyl)prop- 2-en-1-one
C27H22ClNO2
Acta Crystallographica Section E (2010) 66, 2 o374
a=16.2086(5)Å b=13.4760(4)Å c=10.5450(3)Å
α=90.00° β=105.128(2)° γ=90.00°
(<i>E</i>)-1-(6-Chloro-2-methyl-4-phenyl-3-quinolyl)-3-(2-methoxyphenyl)prop- 2-en-1-one
C26H20ClNO2
Acta Crystallographica Section E (2010) 66, 2 o353-o354
a=15.1154(2)Å b=15.4655(2)Å c=17.2400(2)Å
α=90.00° β=104.4180(10)° γ=90.00°
Ethyl 2-acetyl-3-(4-bromoanilino)butanoate
C14H18BrNO3
Acta Crystallographica Section E (2010) 66, 2 o296
a=6.9107(3)Å b=10.1549(4)Å c=11.6457(5)Å
α=88.104(2)° β=81.932(2)° γ=72.872(2)°
6-Chloro-3-[5-(4-fluorophenyl)-1-phenyl-4,5-dihydro-1<i>H</i>-pyrazol-3-yl]- 2-methyl-4-phenylquinoline
C31H23ClFN3
Acta Crystallographica Section E (2010) 66, 2 o304
a=9.4303(2)Å b=28.2155(6)Å c=9.6028(2)Å
α=90.00° β=106.6360(10)° γ=90.00°
(2<i>E</i>)-3-(4-Ethoxyphenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one monohydrate
C27H23NO2,H2O
Acta Crystallographica Section E (2010) 66, 12 o3284
a=17.4256(4)Å b=7.6240(2)Å c=18.4117(4)Å
α=90° β=116.9570(10)° γ=90°
1-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)-3-(3-methoxyphenyl)prop-2-en-1-one
C26H20ClNO2
Acta Crystallographica Section E (2010) 66, 1 o91-o92
a=15.6338(2)Å b=14.0408(2)Å c=10.03210(10)Å
α=90.00° β=108.4620(10)° γ=90.00°
(2<i>E</i>,6<i>E</i>)-2,6-Bis(2,4,5-trimethoxybenzylidene)cyclohexanone
C26H30O7
Acta Crystallographica Section E (2010) 66, 3 o630-o631
a=9.09430(10)Å b=13.49470(10)Å c=18.8293(2)Å
α=90.00° β=100.4490(10)° γ=90.00°
(<i>E</i>)-1,1,4,4-Tetraphenylbut-2-yne-1,4-diol
C28H22O2
Acta Crystallographica Section E (2010) 66, 3 o679
a=11.7760(7)Å b=6.1154(4)Å c=14.7620(9)Å
α=90.00° β=104.930(8)° γ=90.00°
3-Acetyl-6-chloro-2-methyl-4-phenylquinolinium perchlorate
C18H15ClNO,ClO4
Acta Crystallographica Section E (2010) 66, 5 o1192-o1193
a=7.38620(10)Å b=8.8519(2)Å c=13.3378(3)Å
α=92.4770(10)° β=91.9030(10)° γ=99.5500(10)°
1-(2-Methyl-6-nitro-4-phenyl-3-quinolyl)ethanone
C18H14N2O3
Acta Crystallographica Section E (2010) 66, 5 o1237
a=13.297(2)Å b=7.7689(12)Å c=17.9430(19)Å
α=90.00° β=129.099(7)° γ=90.00°
(2<i>E</i>)-3-(4-Bromophenyl)-1-(2-methyl-4-phenyl-3-quinolyl)prop-2-en-1-one
C25H18BrNO
Acta Crystallographica Section E (2010) 66, 5 o1110
a=6.6407(3)Å b=10.0395(4)Å c=15.5193(6)Å
α=92.192(2)° β=95.234(2)° γ=105.869(2)°
Ethyl 2-[5-(4-chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3-yl]-4- methylthiazole-5-carboxylate
C22H17ClFN3O2S
Acta Crystallographica Section E (2010) 66, 11 o2925
a=12.0296(5)Å b=19.4428(6)Å c=9.5847(3)Å
α=90.00° β=112.9220(10)° γ=90.00°
4,5,6,7,8,9-Hexahydro-2<i>H</i>-cycloocta[<i>c</i>]pyrazol-1-ium-3-olate
C9H14N2O
Acta Crystallographica Section E (2010) 66, 11 o3019
a=12.8078(2)Å b=6.77580(10)Å c=10.7096(2)Å
α=90.00° β=111.6200(10)° γ=90.00°
5-Ethyl-2-(4-fluorophenyl)-4-phenoxy-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C17H15FN2O2
Acta Crystallographica Section E (2011) 67, 2 o475
a=15.332(2)Å b=8.6833(14)Å c=11.6066(19)Å
α=90.00° β=109.916(3)° γ=90.00°
1,3-Dimethyl-4-phenylsulfanyl-1<i>H</i>-pyrazol-5-ol
C11H12N2OS
Acta Crystallographica Section E (2011) 67, 3 o633
a=10.9479(2)Å b=11.3470(3)Å c=17.7392(4)Å
α=90.00° β=90.00° γ=90.00°
(<i>E</i>)-4-(1,3-Benzodioxol-5-yl)but-3-en-2-one
C11H10O3
Acta Crystallographica Section E (2011) 67, 3 o583
a=5.3469(3)Å b=16.4849(8)Å c=10.5475(6)Å
α=90.00° β=99.183(5)° γ=90.00°
(2<i>E</i>)-1-(6-Chloro-2-methyl-4-phenylquinolin-3-yl)- 3-(4-chlorophenyl)prop-2-en-1-one
C25H17Cl2NO
Acta Crystallographica Section E (2011) 67, 3 o624
a=11.1704(3)Å b=12.8497(5)Å c=16.0591(6)Å
α=74.914(3)° β=80.603(3)° γ=70.789(3)°
Diethyl 2,6-dimethyl-4-<i>p</i>-tolyl-1,4-dihydropyridine-3,5-dicarboxylate
C20H25NO4
Acta Crystallographica Section E (2009) 65, 10 o2342-o2343
a=10.01750(10)Å b=7.42870(10)Å c=25.0974(3)Å
α=90° β=105.5280(10)° γ=90°
4,8,9,10-Tetrakis(4-fluorophenyl)-1,3-diazatricyclo[3.3.1.1]decan-6-one
C32H24F4N2O
Acta Crystallographica Section E (2009) 65, 7 o1530
a=6.8432(7)Å b=12.5045(11)Å c=28.8930(15)Å
α=90.00° β=92.393(12)° γ=90.00°
2,4,6,8-Tetrakis(2-methoxyphenyl)-3,7-diazabicyclo[3.3.1]nonan-9-one diethyl ether hemisolvate
2(C35H36N2O5),C4H10O
Acta Crystallographica Section E (2009) 65, 10 o2486-o2487
a=13.5607(2)Å b=13.7640(2)Å c=20.3227(3)Å
α=90.00° β=123.1430(10)° γ=90.00°
1,1'-[4-(4-Methoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-diyl]diethanone
C18H21NO3
Acta Crystallographica Section E (2009) 65, 11 o2795
a=12.0781(3)Å b=8.9650(2)Å c=29.3755(8)Å
α=90.00° β=90.00° γ=90.00°
Ethyl 4-(3-hydroxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline- 3-carboxylate
C21H25NO4
Acta Crystallographica Section E (2009) 65, 11 o2664
a=10.8721(4)Å b=16.1255(7)Å c=11.0856(4)Å
α=90.00° β=100.682(2)° γ=90.00°
6-Chloro-3-[5-(3-methoxy-8-methyl-4-quinolyl)-1-phenyl-4,5-dihydro-1<i>H</i>- pyrazol-3-yl]-2-methyl-4-phenylquinoline
C36H29ClN4O
Acta Crystallographica Section E (2009) 65, 11 o2665-o2666
a=14.1209(3)Å b=20.2273(4)Å c=10.1892(2)Å
α=90.00° β=95.3580(10)° γ=90.00°
6-Chloro-2-methyl-4-phenyl-3-[1-phenyl-5-(2-thienyl)-4,5-dihydro-1<i>H</i>- pyrazol-3-yl]quinoline
C29H22ClN3S
Acta Crystallographica Section E (2009) 65, 11 o2707-o2708
a=14.0395(4)Å b=9.4199(3)Å c=19.3020(6)Å
α=90.00° β=114.696(2)° γ=90.00°
Diammonium 1,1',3,3'-tetramethyl-2,2',4,4',6,6'-hexaoxoperhydro- 5,5'-bipyrimidine-5,5'-diide monohydrate
2(H4N),C12H12N4O62,H2O
Acta Crystallographica Section E (2009) 65, 11 o2655-o2656
a=8.53450(10)Å b=12.1579(2)Å c=7.74820(10)Å
α=90.00° β=100.5950(10)° γ=90.00°
1-(6-Chloro-2-methyl-4-phenyl-3-quinolyl)ethanone
C18H14ClNO
Acta Crystallographica Section E (2009) 65, 11 o2688-o2689
a=10.4633(2)Å b=7.79590(10)Å c=17.5925(3)Å
α=90.00° β=90.8870(10)° γ=90.00°
5-Methoxymethyl-4-phenoxy-1<i>H</i>-pyrazol-3-ol
C11H12N2O3
Acta Crystallographica Section E (2009) 65, 12 o3249-o3250
a=8.8876(5)Å b=10.3031(5)Å c=12.0083(6)Å
α=90.00° β=100.917(3)° γ=90.00°
Methyl 6-chloro-2-methyl-4-phenylquinoline-3-carboxylate
C18H14ClNO2
Acta Crystallographica Section E (2010) 66, 1 o169
a=10.828(5)Å b=7.535(4)Å c=18.829(5)Å
α=90.00° β=94.369(5)° γ=90.00°
1,1'-(<i>p</i>-Phenylenedimethylene)dipiperidin-4-one
C18H24N2O2
Acta Crystallographica Section E (2010) 66, 1 o170
a=6.2701(5)Å b=8.0990(6)Å c=15.8978(13)Å
α=90.00° β=98.275(2)° γ=90.00°
3-Acetyl-6-chloro-4-phenylquinolin-2(1<i>H</i>)-one
C17H12ClNO2
Acta Crystallographica Section E (2010) 66, 1 o228
a=10.043(5)Å b=18.663(9)Å c=15.537(7)Å
α=90.00° β=91.811(5)° γ=90.00°
<i>Tert</i>-butyl 3-oxo-2,3,4,5,6,7-hexahydro-1<i>H</i>- pyrazolo[4,3-<i>c</i>]pyridine-5-carboxylate
C11H17N3O3
Acta Crystallographica Section E (2010) 66, 1 o142-o143
a=18.6250(12)Å b=6.0893(5)Å c=10.7414(7)Å
α=90.00° β=104.100(4)° γ=90.00°
2,4,6,8-Tetrakis(4-bromophenyl)-3,7-diazabicyclo[3.3.1]nonan-9-one
C31H24Br4N2O
Acta Crystallographica Section E (2010) 66, 2 o265-o266
a=14.7409(5)Å b=27.7762(10)Å c=7.1538(2)Å
α=90.00° β=101.067(2)° γ=90.00°
Dimethyl 1,4-dihydro-4-(4-methoxyphenyl)-2,6-dimethylpyridine-3,5-dicarboxylate
C18H21NO5
Acta Crystallographica Section E (2010) 66, 3 o587-o588
a=7.4106(3)Å b=9.5715(5)Å c=11.7771(6)Å
α=83.0290(10)° β=83.8340(10)° γ=77.4240(10)°
(<i>E</i>)-<i>N</i>-Benzylidene-4<i>H</i>-1,2,4-triazol-4-amine
C9H8N4
Acta Crystallographica Section E (2010) 66, 3 o558
a=33.0059(11)Å b=4.06390(10)Å c=20.6535(7)Å
α=90.00° β=111.067(2)° γ=90.00°
Dimethyl 4-(3-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C17H19NO5
Acta Crystallographica Section E (2010) 66, 4 o985
a=10.4863(7)Å b=10.4091(7)Å c=14.8702(11)Å
α=90° β=99.259(4)° γ=90°
<i>N</i>,<i>N</i>'-Bis(4-fluorophenyl)urea
C13H10F2N2O
Acta Crystallographica Section E (2010) 66, 6 o1319
a=67.541(4)Å b=4.5750(3)Å c=10.7098(6)Å
α=90.00° β=95.969(2)° γ=90.00°
Dimethyl 4-(3,4-dimethoxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
C19H23NO6
Acta Crystallographica Section E (2010) 66, 6 o1355-o1356
a=7.3883(6)Å b=10.0775(8)Å c=12.3833(10)Å
α=105.372(2)° β=90.255(2)° γ=91.611(2)°
5-Ethyl-4-methyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C6H10N2O
Acta Crystallographica Section E (2010) 66, 6 o1357-o1358
a=8.374(2)Å b=7.2881(16)Å c=11.300(3)Å
α=90.00° β=109.955(5)° γ=90.00°
5-Pentyl-4-phenylsulfonyl-1<i>H</i>-pyrazol-3-ol
C14H18N2O3S
Acta Crystallographica Section E (2010) 66, 6 o1482-o1483
a=10.3425(3)Å b=11.2963(3)Å c=12.8911(3)Å
α=90.00° β=107.4190(10)° γ=90.00°
1-{3-[(4-Oxopiperidin-1-yl)carbonyl]benzoyl}piperidin-4-one
C18H20N2O4
Acta Crystallographica Section E (2010) 66, 8 o1988
a=10.777(5)Å b=11.244(5)Å c=13.665(5)Å
α=101.500(5)° β=92.279(5)° γ=90.009(5)°
1-[6-Chloro-4-(2-chlorophenyl)-2-methyl-3-quinolyl]ethanone
C18H13Cl2N1O1
Acta Crystallographica Section E (2010) 66, 8 o2002
a=10.3105(6)Å b=12.8882(7)Å c=11.7968(7)Å
α=90° β=93.3670(10)° γ=90°
3-Ethyl-4-phenoxy-1-(2,2,2-trifluoroethyl)-1<i>H</i>-pyrazol-5-ol
C13H13F3N2O2
Acta Crystallographica Section E (2010) 66, 8 o1937-o1938
a=9.3490(18)Å b=14.712(3)Å c=20.319(4)Å
α=90.00° β=113.889(8)° γ=90.00°
3-Acetyl-2-methyl-4-phenylquinolin-1-ium chloride
C18H16N1O1,Cl
Acta Crystallographica Section E (2010) 66, 8 o2001
a=9.5046(8)Å b=8.5787(8)Å c=18.2538(16)Å
α=90° β=94.2820(10)° γ=90°
<i>tert</i>-Butyl 4-{[5-(4-chlorophenyl)-1-(4-fluorophenyl)- 1<i>H</i>-pyrazol-3-yl]carbonyl}piperazine-1-carboxylate
C25H26ClFN4O3
Acta Crystallographica Section E (2010) 66, 10 o2682
a=6.0568(5)Å b=12.0047(10)Å c=16.2615(13)Å
α=88.8520(10)° β=81.2060(10)° γ=87.6440(10)°
(2<i>E</i>)-3-(4-Methylphenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one monohydrate
C26H21NO,H2O
Acta Crystallographica Section E (2010) 66, 11 o2710-o2711
a=8.2634(7)Å b=9.0785(7)Å c=14.1176(12)Å
α=91.1370(10)° β=101.5370(10)° γ=100.8200(10)°
3-Hydroxy-2-[(2-hydroxy-4,4-dimethyl-6-oxocyclohex-1- en-1-yl)(3-nitrophenyl)methyl]-5,5-dimethylcyclohex-2-en-1-one
C23H27NO6
Acta Crystallographica Section E (2010) 66, 11 o2806-o2807
a=14.2326(10)Å b=8.6505(6)Å c=16.8410(12)Å
α=90° β=97.7960(10)° γ=90°
1-(4-Fluorophenyl)-3-methyl-4-phenylsulfanyl-1<i>H</i>-pyrazol-5(4<i>H</i>)-one
C16H13FN2OS
Acta Crystallographica Section E (2010) 66, 11 o2815-o2816
a=17.2628(3)Å b=7.283400(10)Å c=11.4877(2)Å
α=90.00° β=91.1380(10)° γ=90.00°
3-(2,5-Dimethylfuran-3-yl)-1<i>H</i>-pyrazol-5-ol--ethyl 3-(propan-2-ylidene)carbazate (1/1)
C6H12N2O2,C9H10N2O2
Acta Crystallographica Section E (2010) 66, 11 o3020-o3021
a=8.6988(17)Å b=9.4830(19)Å c=11.837(4)Å
α=107.293(4)° β=100.354(5)° γ=108.346(3)°
5-Cyclohexyl-4-methyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one monohydrate
C10H16N2O,H2O
Acta Crystallographica Section E (2010) 66, 11 o2760-o2761
a=13.4959(3)Å b=6.24970(10)Å c=13.9268(3)Å
α=90.00° β=112.7820(10)° γ=90.00°
Ethyl 2-methyl-5-oxo-4-(3,4,5-trimethoxyphenyl)-1,4,5,6,7,8- hexahydroquinoline-3-carboxylate
C22H27N1O6
Acta Crystallographica Section E (2010) 66, 9 o2240
a=7.512(2)Å b=10.4020(10)Å c=14.568(3)Å
α=109.77(3)° β=95.420(10)° γ=104.41(2)°
4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3-yl]carbonyl}- <i>N</i>-(4-cyanophenyl)piperazine-1-carboxamide
C28H22ClFN6O2
Acta Crystallographica Section E (2010) 66, 10 o2563-o2564
a=9.9221(3)Å b=21.3339(7)Å c=12.7201(4)Å
α=90.00° β=111.6290(10)° γ=90.00°
1-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3- yl]carbonyl]}piperidin-4-one
C21H17ClFN3O2
Acta Crystallographica Section E (2010) 66, 12 o3233-o3234
a=6.0341(2)Å b=8.2500(3)Å c=10.2448(3)Å
α=108.8370(10)° β=104.7820(10)° γ=92.7920(10)°
5-Isobutyl-4-phenylsulfonyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C13H16N2O3S
Acta Crystallographica Section E (2010) 66, 12 o3050-o3051
a=11.3423(8)Å b=11.9987(9)Å c=12.4657(9)Å
α=98.579(3)° β=113.038(3)° γ=112.882(3)°
4a-Hydroxy-9-(2-methoxyphenyl)-4,4a,5,6,7,8,9,9a-octahydro-3<i>H</i>- xanthene-1,8(2<i>H</i>)-dione
C20H22O5
Acta Crystallographica Section E (2011) 67, 1 o35-o36
a=7.10600(10)Å b=7.88970(10)Å c=15.1001(2)Å
α=91.2850(10)° β=101.2510(10)° γ=101.1290(10)°
4-Methyl-5-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C10H10N2O
Acta Crystallographica Section E (2011) 67, 1 o151-o152
a=25.9337(4)Å b=10.81000(10)Å c=14.1426(2)Å
α=90.00° β=118.9610(10)° γ=90.00°
5-Ethyl-4-phenyl-1<i>H</i>-pyrazol-3(2<i>H</i>)-one
C11H12N2O
Acta Crystallographica Section E (2011) 67, 2 o403-o404
a=11.0898(3)Å b=13.2171(4)Å c=15.0265(5)Å
α=90.00° β=114.539(2)° γ=90.00°
3-Isobutyl-4-phenylsulfanyl-1<i>H</i>-pyrazol-5-ol
C13H16N2OS
Acta Crystallographica Section E (2011) 67, 2 o463-o464
a=20.7342(6)Å b=11.1320(3)Å c=23.1608(6)Å
α=90.00° β=90.00° γ=90.00°
1,1'-[4-(2,4-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5- diyl]diethanone
C17H17Cl2NO2
Acta Crystallographica Section E (2011) 67, 2 o380-o381
a=10.307(4)Å b=13.745(3)Å c=11.312(2)Å
α=90.00° β=93.80(2)° γ=90.00°
(<i>E</i>)-1-(2-Methyl-4-phenylquinolin-3-yl)-3-phenylprop-2-en-1-one
C25H19NO
Acta Crystallographica Section E (2011) 67, 4 o764-o765
a=10.5830(5)Å b=10.2189(5)Å c=18.4509(7)Å
α=90.00° β=114.147(2)° γ=90.00°
1,1'-Bis(4-fluorophenyl)-3,3'-diisobutyl-4,4'-diphenoxy-1<i>H</i>,1'<i>H</i>-4,4'-bipyrazole-5,5'(4<i>H</i>,4'<i>H</i>)-dione
C38H36F2N4O4
Acta Crystallographica Section E (2011) 67, 5 o1036
a=11.3875(5)Å b=11.4582(5)Å c=13.4885(6)Å
α=90.00° β=109.7520(10)° γ=90.00°
Diethyl 2,6-dihydroxy-4-(3-nitrophenyl)- 2,6-bis(trifluoromethyl)piperidine-3,5-dicarboxylate
C19H20F6N2O8
Acta Crystallographica Section E (2012) 68, 2 o400-o401
a=17.7353(16)Å b=15.2025(14)Å c=17.3003(16)Å
α=90.00° β=91.049(2)° γ=90.00°
Diisobutyl 4-(3-ethoxy-4-hydroxyphenyl)-2,6-dimethyl- 1,4-dihydropyridine-3,5-dicarboxylate
C25H35NO6
Acta Crystallographica Section E (2012) 68, 2 o287-o288
a=12.7346(2)Å b=13.1180(2)Å c=15.7404(2)Å
α=71.7660(10)° β=89.8130(10)° γ=76.1500(10)°
3-Ethyl-4-methyl-1<i>H</i>-pyrazol-2-ium-5-olate
C6H10N2O
Acta Crystallographica Section E (2011) 67, 8 o2129
a=9.1299(15)Å b=7.1600(11)Å c=11.374(2)Å
α=90.00° β=113.232(9)° γ=90.00°
<i>N</i>-(4-Methoxyphenyl)-2,6-dimethyl-1,3-dioxan-4-amine
C13H19NO3
Acta Crystallographica Section E (2013) 69, 9 o1490
a=9.6472(6)Å b=13.8194(8)Å c=10.5384(6)Å
α=90.00° β=114.355(3)° γ=90.00°
<i>N</i>-(4-Fluorophenyl)-2,6-dimethyl-1,3-dioxan-4-amine
C12H16FNO2
Acta Crystallographica Section E (2013) 69, 11 o1602
a=10.4924(10)Å b=10.0614(10)Å c=11.0379(11)Å
α=90.00° β=90.136(2)° γ=90.00°
<i>N</i>-(2-Fluorophenyl)-2,6-dimethyl-1,3-dioxan-4-amine
C12H16FNO2
Acta Crystallographica Section E (2013) 69, 10 o1524
a=19.6219(13)Å b=8.1603(6)Å c=15.2396(10)Å
α=90.00° β=95.950(3)° γ=90.00°
2,6-Dimethyl-<i>N</i>-(2-methylphenyl)-1,3-dioxan-4-amine
C13H19NO2
Acta Crystallographica Section E (2013) 69, 10 o1561
a=8.0209(2)Å b=7.8762(2)Å c=20.4293(5)Å
α=90.00° β=99.066(2)° γ=90.00°
<i>N</i>-(4-Bromophenyl)-2,6-dimethyl-1,3-dioxan-4-amine
C12H16BrNO2
Acta Crystallographica Section E (2013) 69, 10 o1579
a=9.9367(5)Å b=13.5660(6)Å c=10.3206(5)Å
α=90.00° β=115.543(3)° γ=90.00°
(<i>E</i>)-3-[4-(Dimethylamino)phenyl]-1-(2-methyl-4-phenylquinolin- 3-yl)prop-2-en-1-one 0.7-hydrate
C27H24N2O,0.7(H2O)
Acta Crystallographica Section E (2011) 67, 6 o1521-o1522
a=9.2653(2)Å b=10.6076(2)Å c=12.2347(2)Å
α=66.4090(10)° β=87.7580(10)° γ=80.3080(10)°
4-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1<i>H</i>-pyrazol-3-yl]carbonyl}- <i>N</i>-ethylpiperazine-1-carboxamide
C23H23ClFN5O2
Acta Crystallographica Section E (2011) 67, 7 o1747-o1748
a=25.8566(6)Å b=10.0475(2)Å c=16.8822(4)Å
α=90.00° β=92.5250(10)° γ=90.00°